Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

Free Radical Biology and Medicine - Tập 38 - Trang 698-710 - 2005
M.B. Kadiiska1, B.C. Gladen1, D.D. Baird1, D. Germolec1, L.B. Graham1, C.E. Parker1, A. Nyska1, J.T. Wachsman1, B.N. Ames2, S. Basu3, N. Brot4, G.A. FitzGerald5, R.A. Floyd6, M. George7, J.W. Heinecke8, G.E. Hatch9, K. Hensley6, J.A. Lawson5, L.J. Marnett10, J.D. Morrow11
1Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, P.O. Box 12233, MD F0-02, Research Triangle Park, NC 27709, USA
2Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA
3Faculty of Medicine, Uppsala University, SE-751 05 Uppsala, Sweden
4Hospital for Special Surgery, Weill Medical College, Cornell University, New York, NY 10029, USA
5The Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA
6Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
7Loyola University Medical Center, Maywood, IL 60153, USA
8Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
9U.S. Environmental Protection Agency, Research Triangle Park, NC, 27711, USA
10Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, TN 37240, USA
11Department of Pharmacological Medicine, School of Medicine, Vanderbilt University, Nashville, TN 37240, USA

Tài liệu tham khảo

1992 Halliwell, 1987, Oxidants and human disease: some new concepts, FASEB J., 1, 358, 10.1096/fasebj.1.5.2824268 Pryor, 1982, Free radical biology: xenobiotics, cancer and aging, Ann. N.Y. Acad. Sci., 393, 1, 10.1111/j.1749-6632.1982.tb31228.x Pryor, 1991, Noninvasive measures of oxidative stress status in humans, Free Radic. Biol. Med., 10, 177, 10.1016/0891-5849(91)90073-C Morrow, 1992, Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids, Proc. Natl. Acad. Sci. USA, 89, 10721, 10.1073/pnas.89.22.10721 Pratico, 2004, F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases, Chem. Phys. Lipids, 128, 165, 10.1016/j.chemphyslip.2003.09.012 Hensley, 2000, Measurement of 3-nitrotyrosine and 5-nitro-γ-tocopherol by high-performance liquid chromatography with electrochemical detection, Free Radic. Biol. Med., 28, 520, 10.1016/S0891-5849(00)00155-6 Davies, 1999, Stable markers of oxidant damage to proteins and their application in the study of human disease, Free Radic. Biol. Med., 27, 1151, 10.1016/S0891-5849(99)00206-3 Risby, 1999, Clinical application of breath biomarkers of oxidative stress status, Free Radic. Biol. Med., 27, 1182, 10.1016/S0891-5849(99)00212-9 De Zwart, 1999, Biomarkers of free radical damage: applications in experimental animals and in humans, Free Radic. Biol. Med., 26, 202, 10.1016/S0891-5849(98)00196-8 Pryor, 1999, Oxidative stress status: OSS, BOSS and “Wild Bill” Donovan, Free Radic. Biol. Med., 27, 1135, 10.1016/S0891-5849(99)00213-0 De Zwart, 1998, Evaluation of urinary biomarkers for radical-induced liver damage in rats treated with carbon tetrachloride, Toxicol. Appl. Pharmacol., 148, 71, 10.1006/taap.1997.8310 Pryor, 2000, Oxidative stress status—the third set, Free Radic. Biol. Med., 28, 837, 10.1016/S0891-5849(00)00274-4 Kadiiska, 2000, Biomarkers of Oxidative Stress Study: are plasma antioxidants markers of CCl4 poisoning?, Free Radic. Biol. Med., 28, 838, 10.1016/S0891-5849(00)00198-2 Jackson, 1989, Defective modulation of noradrenergic neurotransmission by endogenous prostaglandins in aging spontaneously hypertensive rats, J. Pharmacol. Exp. Ther., 250, 9 Cramer, 1991, Iodometric measurement of lipid hydroperoxides in human plasma, Anal. Biochem., 193, 204, 10.1016/0003-2697(91)90010-Q Draper, 1993, A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials, Free Radic. Biol. Med., 15, 353, 10.1016/0891-5849(93)90035-S Porter, 1976, Cyclic peroxides and the thiobarbituric assay, Biochim. Biophys. Acta, 441, 506, 10.1016/0005-2760(76)90247-2 Yeo, 1994, Assay of malondialdehyde in biological fluids by gas chromatography–mass spectrometry, Anal. Biochem., 220, 391, 10.1006/abio.1994.1355 Morrow, 1999, Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress, Methods Enzymol., 300, 3, 10.1016/S0076-6879(99)00106-8 Parker, 2001, An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma, Mol. Biotechnol., 18, 105, 10.1385/MB:18:2:105 Li, 1999, Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine, Proc. Natl. Acad. Sci. USA, 96, 13381, 10.1073/pnas.96.23.13381 Agarwal, 1995, Differential oxidative damage to mitochondrial proteins during aging, Mech. Ageing Dev., 85, 55, 10.1016/0047-6374(95)01655-4 Levine, 1994, Carbonyl assays for determination of oxidatively modified proteins, Methods Enzymol., 233, 346, 10.1016/S0076-6879(94)33040-9 Yan, 2000, Analysis of oxidative modification of proteins, Curr. Protocols Protein Sci., 144, 105 Levine, 1996, Methionine residues as endogenous antioxidants in proteins, Proc. Natl. Acad. Sci. USA, 93, 15036, 10.1073/pnas.93.26.15036 Hensley, 1997, Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection, Anal. Biochem., 251, 187, 10.1006/abio.1997.2281 Heinecke, 1999, Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues, Methods Enzymol., 300, 124, 10.1016/S0076-6879(99)00121-4 Tice, 1995, The single cell gel/Comet assay: a microgel electrophoretic technique for the detection of DNA damage and repair in individual cells, 315 Leuratti, 1998, Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay, Carcinogenesis, 19, 1919, 10.1093/carcin/19.11.1919 Plastaras, 2000, Reactivity and mutagenicity of endogenous DNA oxopropenylating agents: base propenals, malondialdehyde, and N(ε)-oxopropenyllysine, Chem. Res. Toxicol., 13, 1235, 10.1021/tx0001631 Rice-Evans, 1996, Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls, Free Radic. Res., 25, 285, 10.3109/10715769609149053 Recknagel, 1983, A new direction in the study of carbon tetrachloride hepatotoxicity, Life Sci., 33, 401, 10.1016/0024-3205(83)90787-7 Recknagel, 1989, Mechanisms of carbon tetrachloride toxicity, Pharmacol. Ther., 43, 139, 10.1016/0163-7258(89)90050-8 Reinke, 1992, Spin trapping of free radical metabolites of carbon tetrachloride in vitro and in vivo: effect of acute ethanol administration, Toxicol. Appl. Pharmacol., 112, 17, 10.1016/0041-008X(92)90274-V Goeptar, 1995, Oxygen and xenobiotic reductase activities of cytochrome P450, Crit. Rev. Toxicol., 25, 25, 10.3109/10408449509089886 Gutteridge, 1982, Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity, Int. J. Biochem., 14, 649, 10.1016/0020-711X(82)90050-7 Janero, 1990, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med., 9, 515, 10.1016/0891-5849(90)90131-2 Scott, 1997, Markers of free-radical-mediated tissue injury: tales of caution and woe, 401 Draper, 1990, Malondialdehyde determination as index of lipid peroxidation, Methods Enzymol., 186, 421, 10.1016/0076-6879(90)86135-I Jiang, 1992, Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein, Anal. Biochem., 202, 384, 10.1016/0003-2697(92)90122-N Cheeseman, 1990, Methods of measuring lipid peroxidation in biological systems: an overview, 143 Offord, 2000, Markers of oxidative damage and antioxidant protection: current status and relevance to disease, Free Radic. Res., 33, S5 Bird, 1983, Determination of malonaldehyde in biological materials by high-pressure liquid chromatography, Anal. Biochem., 128, 240, 10.1016/0003-2697(83)90371-8 Higdon, 2000, Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes, Am. J. Clin. Nutr., 72, 714, 10.1093/ajcn/72.3.714 Morrow, 1990, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA, 87, 9383, 10.1073/pnas.87.23.9383 Chiabrando, 2002, Identification of metabolites from type III F2-isoprostane diastereoisomers by mass spectrometry, J. Lipid Res., 43, 495, 10.1016/S0022-2275(20)30156-5 Griendling, 2003, Oxidative stress and cardiovascular injury. Part II. Animal and human studies, Circulation, 108, 2034, 10.1161/01.CIR.0000093661.90582.c4 Morrow, 1992, Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: an animal model of lipid peroxidation, J. Clin. Invest., 90, 2502, 10.1172/JCI116143 Moody, 1992, Effect of phenobarbital treatment on carbon tetrachloride-mediated cytochrome P-450 loss and diene conjugate formation, Toxicol. Lett., 61, 213, 10.1016/0378-4274(92)90148-D Degawa, 1993, Inhibition of the induction and activity of hepatic P450IA isozymes by in-vivo administration of carbon tetrachloride to rats, Biol. Pharm. Bull., 16, 1248, 10.1248/bpb.16.1248 Burke, 2000, Specific analysis in plasma and urine of 2,3-dinor-5,6-dihydro-isoprostane F2α-III, a metabolite of isoprostane F2α-III and an oxidation product of γ-linolenic acid, J. Biol. Chem., 275, 2499, 10.1074/jbc.275.4.2499 Meagher, 1999, Alcohol-induced generation of lipid peroxidation products in humans, J. Clin. Invest., 104, 805, 10.1172/JCI5584 Rokach, 2004, Total synthesis of isoprostanes: discovery and quantitation in biological systems, Chem. Phys. Lipids, 128, 35, 10.1016/j.chemphyslip.2003.09.011 Lawson, 1999, Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo, J. Biol. Chem., 274, 24441, 10.1074/jbc.274.35.24441 Pratico, 2000, Increased 8,12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity, Ann. Neurol., 48, 809, 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9 Iuliano, 2001, Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA, J. Am. Coll. Cardiol., 37, 76, 10.1016/S0735-1097(00)01040-8 Ekstrom, 1986, Lipid peroxidation in vivo monitored as ethane exhalation and malondialdehyde excretion in urine after oral administration of chloroform, Acta Pharmacol. Toxicol., 58, 289, 10.1111/j.1600-0773.1986.tb00111.x Draper, 1984, Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues, Lipids, 19, 836, 10.1007/BF02534512 Bull, 1985, Determination of malondialdehyde by ion-pairing high-performance liquid chromatography, Anal. Biochem., 149, 284, 10.1016/0003-2697(85)90506-8 Marnett, 1985, Distribution and oxidation of malondialdehyde in mice, Prostaglandins, 30, 241, 10.1016/0090-6980(85)90188-1 Wang, 2001, Substrate binding is the rate-limiting step in thromboxane synthase catalysis, J. Biol. Chem., 276, 14737, 10.1074/jbc.M009177200 Ledergerber, 1995, Development of a screening assay for the in vitro evaluation of thromboxane A2 synthase inhibitors, J. Enzyme Inhib., 9, 253, 10.3109/14756369509036554 Dannhardt, 1998, Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibition, Arch. Pharm., 331, 359, 10.1002/(SICI)1521-4184(199811)331:11<359::AID-ARDP359>3.0.CO;2-B Davies, 1987, Protein damage and degradation by oxygen radicals: II. Modification of amino acids, J. Biol. Chem., 262, 9902, 10.1016/S0021-9258(18)48019-2 Berlett, 1997, Protein oxidation in aging, disease and oxidative stress, J. Biol. Chem., 272, 20313, 10.1074/jbc.272.33.20313 Dean, 1997, Biochemistry and pathology of radical-mediated protein oxidation, Biochem. J., 324, 1, 10.1042/bj3240001 Giulivi, 1994, Dityrosine: a marker for oxidatively modified proteins and selective proteolysis, Methods Enzymol., 233, 363, 10.1016/S0076-6879(94)33042-5 Chapman, 1989, Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis, J. Rheumatol., 16, 15 Smith, 1991, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 88, 10540, 10.1073/pnas.88.23.10540 Wardman, 1995, Kinetic factors that control the fate of thiyl radicals in cells, Methods Enzymol., 251, 31, 10.1016/0076-6879(95)51108-3 Brot, 1983, Biochemistry and physiological role of methionine sulfoxide residues in proteins, Arch. Biochem. Biophys., 223, 271, 10.1016/0003-9861(83)90592-1 Brot, 1981, Enzymatic reduction of protein bound methionine sulfoxide, Proc. Natl. Acad. Sci. USA, 78, 2155, 10.1073/pnas.78.4.2155 Leeuwenburgh, 1999, Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine, Free Radic. Biol. Med., 27, 186, 10.1016/S0891-5849(99)00071-4 Onorato, 1998, Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease, Ann. N. Y. Acad. Sci., 854, 277, 10.1111/j.1749-6632.1998.tb09909.x Wiseman, 1996, Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer, Biochem. J., 313, 17, 10.1042/bj3130017 Cadet, 1997, Oxidative damage to DNA: formation, measurement and biological significance, Rev. Physiol. Biochem. Pharmacol., 131, 1 Rouzer, 1997, Analysis of the malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectrometry, Chem. Res. Toxicol., 10, 181, 10.1021/tx9601216